ROCKET PHARMACEUTICALS, INC. (RCKT) Operating Income (Loss) USD 2014 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rocket Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • Rocket Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$67.4 M, a 8.33% decline year-over-year.
  • Rocket Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$265 M, a 8.55% decline year-over-year.
  • Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$260 M, a 15.7% decline from 2022.
  • Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$224 M, a 34.1% decline from 2021.
  • Rocket Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$167 M, a 24.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$265 M -$67.4 M -$5.18 M -8.33% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$260 M -$63.3 M +$5.8 M +8.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 -$265 M -$65.4 M -$6.94 M -11.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$259 M -$68.8 M -$14.5 M -26.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 -$244 M -$62.2 M -$19.6 M -46.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$224 M -$69.1 M -$24.7 M -55.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 -$200 M -$58.5 M -$8.84 M -17.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$191 M -$54.2 M -$20.2 M -59.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$171 M -$42.6 M -$3.34 M -8.52% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 -$167 M -$44.3 M +$14.9 M +25.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 -$182 M -$49.6 M -$22.3 M -81.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$160 M -$34 M -$10.5 M -44.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$149 M -$39.2 M -$15.1 M -62.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$134 M -$59.2 M -$39.6 M -201% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$94.7 M -$27.4 M -$8.22 M -42.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$86.5 M -$23.6 M -$5.17 M -28.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$81.3 M -$24.1 M -$5.18 M -27.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$76.2 M -$19.6 M +$6.9 M +26% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$83 M -$19.2 M -$3.83 M -25% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$79.2 M -$18.4 M -$3.52 M -23.7% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$75.7 M -$18.9 M -$4.54 M -31.5% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$71.2 M -$26.5 M -$19.9 M -299% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-08
Q3 2018 -$51.3 M -$15.3 M -$8.61 M -128% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$42.7 M -$14.9 M -$11.4 M -322% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$31.3 M -$14.4 M -$11.5 M -402% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$19.8 M -$6.66 M -$28.7 M -130% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 $8.95 M -$6.73 M +$4 M +37.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-08
Q2 2017 $4.95 M -$3.52 M +$5.26 M +59.9% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-08
Q1 2017 -$307 K -$2.87 M +$7.27 M +71.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-08
Q4 2016 -$7.57 M $22.1 M +$30.3 M Oct 1, 2016 Dec 31, 2016 10-K 2019-03-08
Q3 2016 -$37.9 M -$10.7 M -$5.29 M -97.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$32.6 M -$8.78 M -$5.1 M -138% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$27.5 M -$10.1 M -$7.09 M -232% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$20.4 M -$8.23 M -$6.52 M -381% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$13.9 M -$5.44 M -$3.35 M -161% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$10.5 M -$3.68 M -$1.49 M -67.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 -$9.04 M -$3.05 M -$1.34 M -78.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$7.7 M -$1.71 M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-23
Q3 2014 -$2.09 M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$2.19 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 -$1.71 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.